Benjamin A. Belinka
Chief Executive Officer at Actinobac Biomed, Inc.
Profile
Benjamin A.
Belinka is the founder of Ben Belinka LLC, Durin Technologies, Inc. He is currently the President & Chief Executive Officer at Actinobac Biomed, Inc. Previously, he worked as the Assistant Director-Research & Chemistry at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as a Principal at Virium Pharmaceuticals, Inc., as a Principal at Sandoz Pharmaceuticals Corp., and as a Vice President at Vectramed, Inc. He holds a doctorate degree from The State University of New York.
Benjamin A. Belinka active positions
| Companies | Position | Start |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Chief Executive Officer | 2009-07-16 |
| Ben Belinka LLC | Founder | 2010-04-26 |
Former positions of Benjamin A. Belinka
| Companies | Position | End |
|---|---|---|
Durin Technologies, Inc.
 Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Chief Executive Officer | - |
Virium Pharmaceuticals, Inc.
 Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
| Vectramed, Inc. | Corporate Officer/Principal | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 2009-07-19 |
Training of Benjamin A. Belinka
| The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Virium Pharmaceuticals, Inc.
Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
| Vectramed, Inc. | |
| Ben Belinka LLC | |
Durin Technologies, Inc.
Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Health Services |
- Stock Market
- Insiders
- Benjamin A. Belinka
